JPMORGAN CHASE & CO - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 83 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q2 2018. The put-call ratio across all filers is 1.72 and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2022$5
-99.9%
43,415
-1.3%
0.00%
Q3 2022$7,000
-50.0%
43,974
-18.1%
0.00%
Q2 2022$14,000
-74.5%
53,676
-48.0%
0.00%
Q1 2022$55,000
-16.7%
103,145
-4.1%
0.00%
Q4 2021$66,000
+88.6%
107,590
+211.1%
0.00%
Q3 2021$35,000
-89.8%
34,582
-81.5%
0.00%
Q2 2021$342,000
-44.6%
187,252
-40.2%
0.00%
Q1 2021$617,000
+91.0%
312,978
+20.8%
0.00%
Q4 2020$323,000
+429.5%
259,070
+740.0%
0.00%
Q3 2020$61,000
-68.7%
30,841
+32.5%
0.00%
Q2 2020$195,000
-84.2%
23,285
-90.1%
0.00%
Q1 2020$1,233,000
+24.9%
235,353
+30.2%
0.00%
Q4 2019$987,000
+425.0%
180,779
+367.1%
0.00%
Q3 2019$188,000
+42.4%
38,702
+100.8%
0.00%
Q2 2019$132,000
+16.8%
19,272
+18.6%
0.00%
Q1 2019$113,000
+52.7%
16,250
+27.5%
0.00%
Q4 2018$74,000
-14.9%
12,742
+10.3%
0.00%
Q3 2018$87,000
+70.6%
11,554
+14.1%
0.00%
Q2 2018$51,000
-15.0%
10,130
+2.4%
0.00%
Q1 2018$60,000
-18.9%
9,889
-5.4%
0.00%
Q4 2017$74,000
+2366.7%
10,457
+945.7%
0.00%
Q2 2016$3,0001,0000.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q2 2018
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$1,273,0000.73%
ETF MANAGERS GROUP, LLC 7,062,485$1,787,0000.05%
Ikarian Capital, LLC 862,527$217,0000.04%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 457,209$115,0000.02%
Platform Technology Partners 33,750$9,0000.01%
PINNACLE ASSOCIATES LTD 910,006$230,0000.01%
CJM Wealth Advisers, Ltd. 30,465$7,6830.01%
Mirae Asset Global Investments Co., Ltd. 4,029,171$1,016,0000.00%
Vident Investment Advisory, LLC 267,612$67,0000.00%
Aries Wealth Management 15,400$4,0000.00%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders